Patient preferences in choosing chemotherapy regimens for advanced non-small cell lung cancer

Journal of Supportive Oncology

Volumn 3, Issue 2, 2005, Pages 149-154

  Dubey, Sarita ^a,b,c,d,e   Brown, Roger L ^a,b,c,d,e   Esmond, Sarah L ^a,b,c,d,e   Bowers, Barbara J ^a,b,c,d,e   Healy, Janet M ^a,b,c,d,e   Schiller, Joan H ^a,b,c,d,e  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN MADISON SCHOOL OF NURSING   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^e ALCASE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; DOCTOR PATIENT RELATION; DRUG PREFERENCE; FATIGUE; FEMALE; FEMALE PHYSICIAN; HAIR LOSS; HUMAN; INFECTION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NAUSEA; PARESTHESIA; PATIENT ATTITUDE; PILOT STUDY; QUESTIONNAIRE; SEX DIFFERENCE; SIDE EFFECT; STRESS; TREATMENT REFUSAL; VOMITING;

CARCINOMA, NON-SMALL-CELL LUNG; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATIENT EDUCATION; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; PILOT PROJECTS; QUESTIONNAIRES; SOCIOECONOMIC FACTORS;

EID: 15944375793     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Jemal A,Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
2. Cullen MH, Billingham LJ, Woodroffe CM, et al. Mitomycin, ifosfamide, and cisplatin in unresectable non-small cell lung cancer: effects on survival and quality of life. J Clin Oncol 1999;17:3188-3194.
3. Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N Engl J Med 2002;346:92-98.
4. Silvestri G, Pritchard R, Welch HG. Preferences of chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ 1998;317:771-775.
5. Griffin AM, Butow PN, Coates AS, et al. On the receiving end. V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 1996;7:189-195.
6. Williams PD, Ducey KA, Sears AM, et al.Treatment type and symptom severity among oncology patients by self-report. Int J Nurs Stud 2001;38:359-367.
7. Sun CC, Bodurka DC, Donato ML, et al. Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they changeover time? Gynecol Oncol 2002;87:118-128.
8. Roter DL, Hall JA. Physician gender and patient-centered communication: a critical review of empirical research. Annu Rev Public Health 2004;25:497-519.
9. Zandbelt LC, Smets EM, Oort FJ, Godfried MH, de Haes HC. Satisfaction with the outpatient encounter: a comparison of patients' and physicians' views. J Gen Intern Med 2004;19:1088-1095.
10. McCullagh P. Regression models for ordinal data. J R Stat Soc [Ser B] 1980;42:109-142.
11. Hintze J. NCSS and PASS. Number Cruncher Statistical Systems. Available at:http://www.ncss.com. Accessed January 28, 2005.
12. Tierney AJ, Taylor J, Closs SJ. Knowledge, expectations, and experiences of patients receiving chemotherapy for breast cancer. Scand J Caring Sci 1992;6:75-80.
13. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717.